353P Prognostic role of metastatic sites in a worldwide population of patients with biliary tract cancer treated with cisplatin, gemcitabine, and durvalumab.

Saved in:
Bibliographic Details
Title: 353P Prognostic role of metastatic sites in a worldwide population of patients with biliary tract cancer treated with cisplatin, gemcitabine, and durvalumab.
Authors: Camera, S.1 (AUTHOR), Fornaro, L.2 (AUTHOR), Rimini, M.1 (AUTHOR), Persano, M.1 (AUTHOR), Rizzato, M.D.3 (AUTHOR), Saborowski, A.4 (AUTHOR), Antonuzzo, L.5 (AUTHOR), Rossari, F.1 (AUTHOR), Satake, T.6 (AUTHOR), Peeters, F.7 (AUTHOR), Salani, F.2 (AUTHOR), Bozzarelli, S.8 (AUTHOR), Corallo, S.9 (AUTHOR), Lucchetti, J.10 (AUTHOR), Kim, J.W.11 (AUTHOR), Abidoye, O.12 (AUTHOR), Rapposelli, I.G.13 (AUTHOR), Gallio, C.13 (AUTHOR), Rimassa, L.8 (AUTHOR), Gardini, A. Casadei1 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 1, Vol. 36, pS139-S139. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.05.368